Buch, Englisch, 402 Seiten, HC runder Rücken kaschiert, Format (B × H): 160 mm x 241 mm, Gewicht: 793 g
Reihe: The Receptors
Buch, Englisch, 402 Seiten, HC runder Rücken kaschiert, Format (B × H): 160 mm x 241 mm, Gewicht: 793 g
Reihe: The Receptors
ISBN: 978-1-58829-712-9
Verlag: Humana Press
Comprehensive and cutting-edge, The Cannabinoid Receptors serves as an ideal guidebook to what continues to be a fascinating and vital field.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Molekulare Medizin, Zellbiologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
Weitere Infos & Material
Cannabinoid Receptor Ligands and Structure-Activity Relationships.- Structure–Activity Relationships of Classical Cannabinoids.- Endocannabinoids and Their Synthetic Analogs.- Cannabimimetic Indoles, Pyrroles, and Indenes: Structure–Activity Relationships and Receptor Interactions.- Structure–Activity Relationships and Conformational Freedom of CB1 Receptor Antagonists and Inverse Agonists.- Cannabinoid Receptor Biology.- Cannabinoid Receptor Genetics and Evolution.- Cannabinoid Receptor Molecular Pharmacology.- Cannabinoid Receptor Signal Transduction Pathways.- Cannabinoid Agonist and Inverse Agonist Regulation of G Protein Coupling.- Molecular Biology of Cannabinoid Receptors: Mutational Analyses of the CB Receptors.- Models of Cannabinoid Inverse Agonism, Neutral Antagonism, and Agonism: Tools for Rational Drug Design.- The Endocannabinoid System.- Endocannabinoids as Modulators of Synaptic Signaling.- New Insights into the Endocannabinoid System by Using Cannabinoid Receptor Knockout Mice.- Cannabinoid Receptor Pharmacology.- Preclinical Pharmacological and Brain Bioassay Systems for CB1 Cannabinoid Receptors.- Therapeutic Applications for Agents that Act at CB1 and CB2 Receptors.